Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2006-06-13
2006-06-13
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S001210, C424S009321, C424S009510, C424S417000
Reexamination Certificate
active
07060291
ABSTRACT:
A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.
REFERENCES:
patent: 5534259 (1996-07-01), Zalipsky et al.
patent: 5935599 (1999-08-01), Dadey
patent: 6287857 (2001-09-01), O'Riordan et al.
Huang, A. et al., “Monoclonal Antibody Covalenty Coupled With Fatty Acid”, The Journal of Biological Chemistry, Sep. 10, vol. 255, No. 17, pp. 8015-8018.
Ahl Patrick
Cabral-Lilly Donna
Erukulla Ravi
Janoff Andrew
Meers Paul R.
Foley & Hoag LLP
Kishore Gollamudi S.
Transave Inc.
LandOfFree
Modular targeted liposomal delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modular targeted liposomal delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modular targeted liposomal delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669824